Evidences have shown that chronic inflammation induced by TLR ligands is associated with carcinogenesis; moreover, cancer cells express TLRs to facilitate inflammation, which further support tumor development and metastasis.[33] Huang et al believed that TLR2 silencing might be a potential siRNA-based gene therapy for hepatocarcinoma. The gene discussed is TLR2; the disease is cancer.